About Seraxis
Seraxis is a Germantown, Maryland biotechnology company developing stem cell-derived pancreatic islet replacement therapies for type 1 diabetes, including its SR-02 program and gene-edited SR-03. It is merging with Sernova to form BetaNova Biotherapeutics.